CME Cme Group Inc

Price (delayed)

$175.68

Market cap

$63.2B

P/E Ratio

23.93

Dividend/share

$4.5

EPS

$7.34

Enterprise value

$204.48B

CME Group Inc. is a global markets company. It is the world's largest financial derivatives exchange, and trades in asset classes that include agricultural products, currencies, energy, interest rates, metals, ...

Highlights
CME's P/E is 15% below its 5-year quarterly average of 28.3 and 15% below its last 4 quarters average of 28.0
CME's revenue is up by 7% year-on-year and by 2.4% since the previous quarter
The company's net income rose by 10% YoY but it fell by 8% QoQ
The EPS has declined by 9% since the previous quarter but it is up by 8% year-on-year

Key stats

What are the main financial stats of CME
Market
Shares outstanding
359.73M
Market cap
$63.2B
Enterprise value
$204.48B
Valuations
Price to earnings (P/E)
23.93
Price to book (P/B)
2.24
Price to sales (P/S)
12.71
EV/EBIT
56.38
EV/EBITDA
51.2
EV/Sales
41.23
Earnings
Revenue
$4.96B
EBIT
$3.63B
EBITDA
$3.99B
Free cash flow
$2.69B
Per share
EPS
$7.34
Free cash flow per share
$7.5
Book value per share
$78.6
Revenue per share
$13.82
TBVPS
$411.21
Balance sheet
Total assets
$178.43B
Total liabilities
$150.18B
Debt
$143.41B
Equity
$28.25B
Working capital
$2.68B
Liquidity
Debt to equity
5.08
Current ratio
1.02
Quick ratio
1.02
Net debt/EBITDA
35.38
Margins
EBITDA margin
80.5%
Gross margin
100%
Net margin
54%
Operating margin
60.1%
Efficiency
Return on assets
1.4%
Return on equity
9.5%
Return on invested capital
2.3%
Return on capital employed
9.6%
Return on sales
73.1%
Dividend
Dividend yield
2.56%
DPS
$4.5
Payout ratio
61.3%

CME stock price

How has the Cme Group stock price performed over time
Intraday
-0.62%
1 week
0.35%
1 month
4.77%
1 year
-21.3%
YTD
4.47%
QTD
4.47%

Financial performance

How have Cme Group's revenue and profit performed over time
Revenue
$4.96B
Gross profit
$4.96B
Operating income
$2.98B
Net income
$2.68B
Gross margin
100%
Net margin
54%
The operating income is up by 18% YoY and by 4.4% QoQ
The net margin has declined by 11% since the previous quarter but it has grown by 2.9% year-on-year
The company's net income rose by 10% YoY but it fell by 8% QoQ
Cme Group's operating margin has increased by 10% YoY

Growth

What is Cme Group's growth rate over time

Valuation

What is Cme Group stock price valuation
P/E
23.93
P/B
2.24
P/S
12.71
EV/EBIT
56.38
EV/EBITDA
51.2
EV/Sales
41.23
CME's P/E is 15% below its 5-year quarterly average of 28.3 and 15% below its last 4 quarters average of 28.0
The EPS has declined by 9% since the previous quarter but it is up by 8% year-on-year
CME's price to book (P/B) is 17% lower than its last 4 quarters average of 2.7 and 14% lower than its 5-year quarterly average of 2.6
The equity has grown by 3.6% year-on-year
The P/S is 20% lower than the last 4 quarters average of 15.8 and 12% lower than the 5-year quarterly average of 14.5
CME's revenue is up by 7% year-on-year and by 2.4% since the previous quarter

Efficiency

How efficient is Cme Group business performance
Cme Group's return on equity has decreased by 10% QoQ but it has increased by 4.4% YoY
The ROIC has contracted by 8% YoY and by 4.2% from the previous quarter
The return on sales has declined by 8% since the previous quarter but it is up by 3.5% year-on-year
Cme Group's return on assets has decreased by 7% QoQ and by 7% YoY

Dividends

What is CME's dividend history
DPS
$4.5
Dividend yield
2.56%
Payout ratio
61.3%
Recent dividends

Financial health

How did Cme Group financials performed over time
Cme Group's total assets is 19% more than its total liabilities
Cme Group's total liabilities has decreased by 6% YoY
Cme Group's total assets has decreased by 4.5% YoY
The debt to equity has contracted by 9% YoY
The debt has declined by 6% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.